bexlex
New Member
- Joined
- Feb 10, 2013
- Messages
- 1,278
- Reaction score
- 3
i have a huge issue with this! If dc's are distributing their drug under the animal rule, than that company should not be able to utilize this crisis; the crisis that enabled them to get approval by the fda, under the animal rule in the first place, to conduct a typical quantitative study. Imo, if you've got it, you give it, and you can utilize the outcome information gained from that but to withhold potential live-saving treatment in/during an outbreak is unethical. This is bs!
^^^^this!!